文献速递头颈外科

腮腺恶性肿瘤术前活检的使用差异及其对手术切缘的影响

Preoperative biopsy in parotid malignancies: Variation in use and impact on surgical margins.
PubMed 文献 · Laryngoscope · 2019-08-14

该回顾性队列研究纳入2004-2014年美国国家癌症数据库5533例接受手术的腮腺恶性肿瘤患者,分析术前活检的使用率、预测因素及其与手术切缘的关系。结果显示术前活检使用率为26.0%,且与年龄、临床T/N分期、学术中心、高手术量中心及较晚年份相关;在临床T1期和年龄小于61岁的患者中,活检与阳性切缘风险降低相关。

要点

  • 腮腺恶性肿瘤术前活检全国使用率低(26.0%),但随时间呈上升趋势。
  • 高龄、晚期临床T/N分期、学术中心及高手术量中心更倾向于行术前活检。
  • 在临床T1期和年龄小于61岁患者中,术前活检与阳性切缘风险降低相关。

核心结论

  • 腮腺恶性肿瘤术前活检使用率低但逐年增加,在年轻和早期临床分期患者中与阳性切缘风险降低相关。

研究设计与样本

  • 回顾性队列研究,纳入2004-2014年美国国家癌症数据库5533例接受手术的腮腺恶性肿瘤患者。

主要发现

  • 术前活检使用率为26.0%。

临床怎么用

  • 对于年轻及早期临床分期的腮腺恶性肿瘤患者,可考虑术前活检以降低阳性切缘风险,可能减少再次手术或辅助治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Determine rate of preoperative biopsy in parotid malignancies, identify factors associated with its use, and its association with surgical margins. STUDY DESIGN: Retrospective cohort. SETTING: Commission on Cancer-Accredited Institutions. SUBJECTS AND METHODS: We included 5533 patients treated surgically for a parotid malignancy 2004-2014 in the National Cancer Database. Chi-squared tests, univariable, and multivariable logistic regressions were used to evaluate predictors of preoperative biopsy (defined as needle, aspiration, or incisional), and associate biopsy with surgical margins. RESULTS: Preoperative biopsy was utilized in 26.0% of patients. Biopsy was more likely in patients >60 years (odds ratio [OR]: 1.19, P = .035), advanced clinical T stage (vs. T1,T2 OR: 1.23, P = .009; T3 OR: 1.26, P = .026; T4A OR: 2.05, P < .001), advanced clinical N stage (vs. N0, N1: OR: 1.39, P = .013; N2/3: OR: 1.63, P < .001), in academic centers (OR: 1.18, P < .024), and in higher volume centers (vs. low, medium OR: 1.28, P = .002; high OR: 2.16, P < .001). Biopsy use increased over time (vs. 2004-2006, 2007-2010 OR: 1.20, P = .047; 2011-2014 OR: 1.39, P < .001). Biopsy was associated with a reduced risk of positive margins in patients with clinical T1 stage (OR: 0.70, P = .012), and younger than 61 (OR: 0.79, P = .036). CONCLUSION: The national rate of preoperative biopsy in parotid malignancy is low at 26.0%, but has increased over time. Preoperative biopsy is associated with a reduced risk of positive margins in younger patients and those with early clinical stage, suggesting its increased use may improve surgical outcomes and decrease reoperation or adjuvant therapy in these subgroups of patients. LEVEL OF EVIDENCE: 3 Laryngoscope, 130:1450-1458, 2020.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Benchetrit L, Torabi SJ, Morse E, et al. Preoperative biopsy in parotid malignancies: Variation in use and impact on surgical margins. Laryngoscope. 2019. PMID: 31411749. doi:10.1002/lary.28224

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。